Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Meichuang Medical Technology

Request full access

Medical device manufacturer revolutionizes patient care with innovative endoscopic solutions

Suzhou Shi, ChinaFounded 2021Health Tech & Medtech

About Suzhou Meichuang Medical Technology

Suzhou Meichuang Medical Technology Co., Ltd. ("Meichuang Medical") is a medical device company established in February 2021, focusing on developing and commercializing high-end devices for peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance. The company was founded by Liu Wenjing, who serves as Chairman and CEO and has over 30 years of experience in the peripheral vascular and tumor intervention field. His journey to founding Meichuang Medical was driven by the realization that mastering core technology was essential for long-term viability, a conclusion reached after experiencing market volatility and supply chain vulnerabilities while acting as a Chinese distributor for imported medical products.

The company's core strategic advantage lies in its successful development and mass production of medical-grade expanded polytetrafluoroethylene (ePTFE), a critical material for high-end devices like vascular stent-grafts and artificial blood vessels. This achievement positions Meichuang as the first domestic company in China to scale the production of this material, breaking a long-standing monopoly held by foreign corporations and addressing a key bottleneck in the domestic supply chain. The company's business model is centered on leveraging this proprietary material platform to develop a diversified product pipeline while also supplying customized ePTFE materials to other device manufacturers. This dual approach mitigates supply chain risks for its partners and accelerates the product development cycle. The company generates revenue through the sale of its medical devices and core material components.

Meichuang Medical operates a global R&D footprint with a 5,400 sq. meter R&D and manufacturing base at its headquarters in Suzhou, a 1,300 sq. meter R&D center in Shanghai, and a new technology research hub in California, USA. This structure supports a robust pipeline that includes various stent-grafts, artificial blood vessels, and patches. The company has already secured certification for 15 products. To fuel its growth, Meichuang has attracted significant investment, completing multiple funding rounds, including an over 100 million RMB A+ round in January 2025 and a B round of a similar scale in June 2025, with participation from notable investors like HongShan (formerly Sequoia China), Efeng Capital, and Su Venture Capital.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
22.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
medical implants, Surgery, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jun 2025 $14M $55M Zhejiang Paradise Silicon Valley Asset Management Group · Su Venture Capital · VCBeat ↗
SERIES A✓Equity / VC Jan 2025 $14M $55M Tsing Song Capital · Industrial Securities Capital · HSG · Efung Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Meichuang Medical Technology website traffic

Latest recorded traffic for Suzhou Meichuang Medical Technology is 1.1K monthly website visits, up 189.5% over the last three months.

Latest monthly visits1.1K 3-month web change+189.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suzhou Meichuang Medical Technology in the Suzhou Shi ecosystem

Live from Dealroom

The Suzhou Meichuang Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • HSG
  • Efung Capital
  • Tsing Song Capital
  • Industrial Securities Capital
  • Zhejiang Paradise Silicon Valley Asset Management Group
  • Su Venture Capital
  • VCBeat
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Suzhou Shi HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Meichuang Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Meichuang Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.